These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33781585)

  • 21. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
    Barrett K; Habib Bedwani N; Arya S; Bhargava A
    Br J Surg; 2020 Oct; 107(11):e531-e532. PubMed ID: 32871025
    [No Abstract]   [Full Text] [Related]  

  • 23. The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic.
    Kortlever TL; de Jonge L; Wisse PHA; Seriese I; Otto-Terlouw P; van Leerdam ME; Spaander MCW; Dekker E; Lansdorp-Vogelaar I
    Prev Med; 2021 Oct; 151():106643. PubMed ID: 34217421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects.
    Fisher-Borne M; Isher-Witt J; Comstock S; Perkins RB
    Prev Med; 2021 Oct; 151():106681. PubMed ID: 34217422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of COVID-19 on the detection and management of colorectal cancer in England.
    Tiernan JP; Davies MM;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):342. PubMed ID: 33857442
    [No Abstract]   [Full Text] [Related]  

  • 26. Improving Colorectal Cancer Screening at an Employer-Sponsored Health Plan During the COVID-19 Pandemic.
    Kim JS; Bakr O; Xu M; Hochman M; Pagán VM
    J Gen Intern Med; 2022 Apr; 37(5):1334-1336. PubMed ID: 35129771
    [No Abstract]   [Full Text] [Related]  

  • 27. Colorectal Screening During the COVID-19 Pandemic: Delayed but Not Forgotten.
    Vaziri H; Anderson JC
    Dig Dis Sci; 2023 Dec; 68(12):4282-4284. PubMed ID: 37794296
    [No Abstract]   [Full Text] [Related]  

  • 28. The COVID-19 pandemic and colorectal cancer prevention: God tempers the wind to the shorn lamb.
    Pellisé M
    Endoscopy; 2020 Oct; 52(10):877-878. PubMed ID: 32967017
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of COVID-19 on colorectal cancer early diagnosis pathway: retrospective cohort study.
    Abdellatif M; Salama Y; Alhammali T; Eltweri AM
    Br J Surg; 2021 Apr; 108(4):e146-e147. PubMed ID: 33792641
    [No Abstract]   [Full Text] [Related]  

  • 30. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain).
    Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M
    Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of the COVID-19 pandemic on adherence to first-round colorectal cancer screening program: a public health issue.
    Fedeli P; Sciurti A; Zullo A; Sinopoli A; Baccolini V
    J Gastrointestin Liver Dis; 2022 Sep; 31(3):356-358. PubMed ID: 36112709
    [No Abstract]   [Full Text] [Related]  

  • 32. Navigating the storm of COVID-19 for patients with suspected bowel cancer.
    D'Souza N; Abulafi M
    Br J Surg; 2020 Jun; 107(7):e204. PubMed ID: 32400893
    [No Abstract]   [Full Text] [Related]  

  • 33. Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.
    Jen GH; Yen AM; Hsu CY; Chiu HM; Chen SL; Chen TH
    Prev Med; 2021 Oct; 151():106597. PubMed ID: 34217416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact on colorectal cancer in COVID-19 pandemic.
    Altaf K; Tan J; Parvaiz A; Ahmed S
    Br J Surg; 2020 Jul; 107(8):e261. PubMed ID: 32472562
    [No Abstract]   [Full Text] [Related]  

  • 35. The Impact of COVID-19 Pandemic and Coverage of Follow-Up Colonoscopy on Choice of Colorectal Cancer Screening Modalities.
    Tetali B; Fendrick AM; Menees S
    Popul Health Manag; 2024 Feb; 27(1):87-89. PubMed ID: 37930706
    [No Abstract]   [Full Text] [Related]  

  • 36. Faecal immunochemical testing in the COVID-19 era: balancing risk and costs.
    Arasaradnam RP; Bhala N; Evans C; Greenaway J; Logan R; Penman I; Seward E; Singh B; Smith S; Stephenson JA; Waugh N;
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):717-719. PubMed ID: 32526209
    [No Abstract]   [Full Text] [Related]  

  • 37. Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
    Habib Bedwani N; English W; Coda S; Akinlade F; Elzayat I; Seward EW; Hayee B; Hanson M; Banerjee S
    Br J Surg; 2021 Jan; 108(1):e18-e19. PubMed ID: 33640923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the COVID-19 pandemic on colorectal cancer service provision.
    CRC COVID Research Collaborative
    Br J Surg; 2020 Oct; 107(11):e521-e522. PubMed ID: 32856751
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of patients with colorectal cancer in COVID-19 pandemic hospital.
    Catal O; Ozer B; Sit M
    Bratisl Lek Listy; 2021; 122(4):293-296. PubMed ID: 33729824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy.
    Rottoli M; Gori A; Pellino G; Flacco ME; Martellucci C; Spinelli A; Poggioli G;
    JAMA Netw Open; 2022 Nov; 5(11):e2243119. PubMed ID: 36409496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.